US conditionally clears Integra/Codman Neuro after UK waves through
Integra LifeSciences has agreed to divest a range of healthcare product lines to nab US clearance for its acquisition of Johnson & Johnson’s neurosurgery medical products business – a deal already unconditionally cleared in the UK on the de minimis exception.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10